Medicskin Holdings Ltd. (8307) AI Stock Analysis

• Market Cap: HK$52.77M
• Dividend Yield: N/A
• Average Volume (3M): 344.27K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.80
• Revenue Growth: -6.31%
• EPS Growth: -64.44%
• Country: HK
• Employees: 29
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Care Facilities
• EPS (TTM): >-0.01
• Shares Outstanding: 396,736,000
• 10 Day Avg. Volume: 195,600
• 30 Day Avg. Volume: 344,266
• PEG Ratio: 0.19
• Price to Book (P/B): 6.99
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 106.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: ―

Medicskin Holdings Ltd. faces significant challenges, primarily driven by its negative profitability and operational inefficiencies, as reflected in the financial performance. Technical analysis suggests bearish momentum, compounded by a negative P/E ratio which indicates potential overvaluation. The lack of corporate events or earnings call data means no additional factors influence the current outlook.

Medicskin Holdings Ltd. Business Overview & Revenue Model

Company Description

Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong. It operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company also offers derma fillers and facial contouring, intense focused ultrasound and ultrasound, radio frequency, lasers and light sources, laser and RF energy, and other treatments; skincare products; and health management services. In addition, it provides preventive health care services, such as genetic tests, history and physical examination, laboratory tests, diagnostics and imaging, and body check services; men's face, skin, and body care services; and shingles and human papillomavirus vaccines. The company was founded in 2000 and is headquartered in Central, Hong Kong. Medicskin Holdings Limited is a subsidiary of Topline Worldwide Limited.

How the Company Makes Money

Medicskin Holdings Ltd. generates revenue through the provision of medical skin care services and the sale of related skincare products. The company's primary income stream comes from offering a variety of aesthetic medical treatments, which include both non-invasive and minimally invasive procedures performed at its centers. Revenue is augmented by the sale of skincare products that complement the treatments offered. The company may also engage in partnerships with skincare product manufacturers and suppliers to enhance its product offerings and expand its customer base. Factors such as the growing demand for aesthetic treatments and advancements in dermatological technology contribute significantly to its earnings.

Medicskin Holdings Ltd. Financial Statement Overview

Summary

Medicskin Holdings Ltd. shows mixed financial performance. Revenue growth is positive, but the company struggles with profitability and operational efficiency. The balance sheet reflects moderate leverage with some financial risks, while cash flows provide a more encouraging picture of liquidity and operational cash generation. Continuous improvement in profitability and operational efficiency is essential for future financial health.

Income Statement

The company experienced a revenue growth of 7.89% year-over-year, but it reported a net loss for the current year. The gross profit margin decreased significantly from previous periods. The EBIT margin is zero, indicating operational challenges, though the EBITDA margin improved slightly to 13.79%.

Balance Sheet

The debt-to-equity ratio is relatively high at 0.53, suggesting moderate leverage. The equity ratio stands at 27.34%, indicating a moderate reliance on equity financing. The ROE is negative due to net losses, which is a concern for shareholder returns.

Cash Flow

Strong free cash flow growth and improved operating cash flow have been achieved, with the operating cash flow to net income ratio indicating better cash management. However, the free cash flow to net income ratio is impacted by ongoing net losses.

Breakdown	TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	47.56M	49.13M	45.54M	49.15M	41.71M	48.05M
Gross Profit	14.36M	39.39M	36.68M	42.14M	34.40M	39.22M
EBITDA	-1.62M	6.78M	6.40M	14.55M	11.62M	5.98M
Net Income	-2.96M	-3.05M	-2.98M	3.92M	953.00K	-3.24M
Balance Sheet
Total Assets	48.97M	40.06M	46.37M	56.67M	58.84M	77.94M
Cash, Cash Equivalents and Short-Term Investments	12.94M	6.93M	6.37M	15.47M	30.33M	42.91M
Total Debt	17.84M	5.76M	11.93M	18.67M	6.42M	12.87M
Total Liabilities	43.44M	32.48M	35.21M	42.49M	38.85M	47.54M
Stockholders Equity	8.91M	10.95M	14.47M	17.43M	23.45M	35.49M
Cash Flow
Free Cash Flow	7.75M	9.12M	946.00K	2.33M	6.84M	13.21M
Operating Cash Flow	8.67M	10.52M	3.25M	4.29M	9.15M	14.91M
Investing Cash Flow	-844.00K	-1.40M	-5.67M	-1.82M	-1.65M	39.02M
Financing Cash Flow	1.77M	-7.21M	-6.74M	-17.94M	-21.03M	-27.23M

Medicskin Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.13
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8307, the sentiment is Negative. The current price of 0.13 is below the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.17, and below the 200-day MA of 0.17, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 28.88 is Positive, neither overbought nor oversold. The STOCH value of 14.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8307.

Medicskin Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	HK$15.14B	5.55	-7.43%	4.45%	11.60%	-21.06%
8357	60 Neutral	HK$106.08M	―	-1.41%	―	-13.38%	78.75%
8143	51 Neutral	HK$163.46M	―	-18.22%	―	-56.16%	62.50%
8307	47 Neutral	HK$52.77M	―	-44.60%	―	-6.31%	-64.44%
8161	47 Neutral	HK$14.35M	1.78	105.83%	―	5.73%	75.18%
2135	46 Neutral	HK$70.19M	―	-48.87%	―	3.14%	-57.92%
8437		HK$10.66M	―		―	―	―